Works by Sepulveda, Juan Manuel

Results: 19
    1

    Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial.

    Published in:
    Cancers, 2022, v. 14, n. 10, p. 2393, doi. 10.3390/cancers14102393
    By:
    • Martínez-García, María;
    • Velasco, Guillermo;
    • Pineda, Estela;
    • Gil-Gil, Miguel;
    • Alameda, Francesc;
    • Capellades, Jaume;
    • Martín-Soberón, Mari Cruz;
    • López-Valero, Israel;
    • Tovar Ambel, Elena;
    • Foro, Palmira;
    • Taus, Álvaro;
    • Arumi, Montserrat;
    • Hernández-Laín, Aurelio;
    • Sepúlveda-Sánchez, Juan Manuel
    Publication type:
    Article
    2
    3

    Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 9, p. 1670, doi. 10.1093/neuonc/noae053
    By:
    • Roth, Patrick;
    • Gorlia, Thierry;
    • Reijneveld, Jaap C;
    • Vos, Filip de;
    • Idbaih, Ahmed;
    • Frenel, Jean-Sébastien;
    • Rhun, Emilie Le;
    • Sepulveda, Juan Manuel;
    • Perry, James;
    • Masucci, G Laura;
    • Freres, Pierre;
    • Hirte, Hal;
    • Seidel, Clemens;
    • Walenkamp, Annemiek;
    • Lukacova, Slavka;
    • Meijnders, Paul;
    • Blais, Andre;
    • Ducray, Francois;
    • Verschaeve, Vincent;
    • Nicholas, Garth
    Publication type:
    Article
    4

    3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 7, p. 1302, doi. 10.1093/neuonc/noae037
    By:
    • Tabouret, Emeline;
    • Furtner, Julia;
    • Graillon, Thomas;
    • Silvani, Antonio;
    • Rhun, Emilie Le;
    • Soffietti, Riccardo;
    • Lombardi, Giuseppe;
    • Sepúlveda-Sánchez, Juan Manuel;
    • Brandal, Petter;
    • Bendszus, Martin;
    • Golfinopoulos, Vassilis;
    • Gorlia, Thierry;
    • Weller, Michael;
    • Sahm, Felix;
    • Wick, Wolfgang;
    • Preusser, Matthias
    Publication type:
    Article
    5

    Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: A phase I, "window-of-opportunity" study.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 6, p. 1113, doi. 10.1093/neuonc/noac263
    By:
    • Moreno, Victor;
    • Sepúlveda, Juan Manuel;
    • Reardon, David A;
    • Pérez-Núñez, Ángel;
    • León, Pedro González;
    • Hanna, Bishoy;
    • Filvaroff, Ellen;
    • Aronchik, Ida;
    • Chang, Henry;
    • Amoroso, Barbara;
    • Zuraek, Marlene;
    • Sanchez-Perez, Tania;
    • Mendez, Cristina;
    • Stephens, Daniel;
    • Nikolova, Zariana;
    • Vogelbaum, Michael A
    Publication type:
    Article
    6
    7

    Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.

    Published in:
    Neuro-Oncology, 2023, v. 25, n. 1, p. 123, doi. 10.1093/neuonc/noac099
    By:
    • Omuro, Antonio;
    • Brandes, Alba A;
    • Carpentier, Antoine F;
    • Idbaih, Ahmed;
    • Reardon, David A;
    • Cloughesy, Timothy;
    • Sumrall, Ashley;
    • Baehring, Joachim;
    • van den Bent, Martin;
    • Bähr, Oliver;
    • Lombardi, Giuseppe;
    • Mulholland, Paul;
    • Tabatabai, Ghazaleh;
    • Lassen, Ulrik;
    • Sepulveda, Juan Manuel;
    • Khasraw, Mustafa;
    • Vauleon, Elodie;
    • Muragaki, Yoshihiro;
    • Giacomo, Anna Maria Di;
    • Butowski, Nicholas
    Publication type:
    Article
    8

    Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 5, p. 755, doi. 10.1093/neuonc/noab243
    By:
    • Preusser, Matthias;
    • Silvani, Antonio;
    • Rhun, Emilie Le;
    • Soffietti, Riccardo;
    • Lombardi, Giuseppe;
    • Sepulveda, Juan Manuel;
    • Brandal, Petter;
    • Brazil, Lucy;
    • Bonneville-Levard, Alice;
    • Lorgis, Veronique;
    • Vauleon, Elodie;
    • Bromberg, Jacoline;
    • Erridge, Sara;
    • Cameron, Alison;
    • Lefranc, Florence;
    • Clement, Paul M;
    • Dumont, Sarah;
    • Sanson, Marc;
    • Bronnimann, Charlotte;
    • Balaná, Carmen
    Publication type:
    Article
    9

    Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 8, p. 1415, doi. 10.1093/neuonc/noaa115
    By:
    • van den Bent, Martin;
    • Eoli, Marica;
    • Sepulveda, Juan Manuel;
    • Smits, Marion;
    • Walenkamp, Annemiek;
    • Frenel, Jean-Sebastian;
    • Franceschi, Enrico;
    • Clement, Paul M;
    • Chinot, Olivier;
    • Vos, Filip de;
    • Whenham, Nicolas;
    • Sanghera, Paul;
    • Weller, Michael;
    • Dubbink, H J;
    • French, Pim;
    • Looman, Jim;
    • Dey, Jyotirmoy;
    • Krause, Scott;
    • Ansell, Pete;
    • Nuyens, Sarah
    Publication type:
    Article
    10

    A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 12, p. 1851, doi. 10.1093/neuonc/noaa107
    By:
    • Balana, Carmen;
    • Vaz, Maria Angeles;
    • Sepúlveda, Juan Manuel;
    • Mesia, Carlos;
    • Barco, Sonia del;
    • Pineda, Estela;
    • Muñoz-Langa, Jose;
    • Estival, Anna;
    • Peñas, Ramón de las;
    • Fuster, Jose;
    • Gironés, Regina;
    • Navarro, Luis Miguel;
    • Gil-Gil, Miguel;
    • Alonso, Miriam;
    • Herrero, Ana;
    • Peralta, Sergio;
    • Olier, Clara;
    • Perez-Segura, Pedro;
    • Covela, Maria;
    • Martinez-García, Maria
    Publication type:
    Article
    11

    INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 684, doi. 10.1093/neuonc/noz222
    By:
    • Bent, Martin Van Den;
    • Eoli, Marica;
    • Sepulveda, Juan Manuel;
    • Smits, Marion;
    • Walenkamp, Annemiek;
    • Frenel, Jean-Sebastian;
    • Franceschi, Enrico;
    • Clement, Paul M;
    • Chinot, Olivier;
    • Vos, Filip De;
    • Whenham, Nicolas;
    • Sanghera, Paul;
    • Weller, Michael;
    • Dubbink, H J;
    • French, Pim;
    • Looman, Jim;
    • Dey, Jyotirmoy;
    • Krause, Scott;
    • Ansell, Pete;
    • Nuyens, Sarah
    Publication type:
    Article
    12

    Defining EGFR amplification status for clinical trial inclusion.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 10, p. 1263, doi. 10.1093/neuonc/noz096
    By:
    • French, Pim J;
    • Eoli, Marica;
    • Sepulveda, Juan Manuel;
    • Heer, Iris de;
    • Kros, Johan M;
    • Walenkamp, Annemiek;
    • Frenel, Jean-Sebastien;
    • Franceschi, Enrico;
    • Clement, Paul M;
    • Weller, Michael;
    • Ansell, Peter;
    • Looman, Jim;
    • Bain, Earle;
    • Morfouace, Marie;
    • Gorlia, Thierry;
    • van den Bent, Martin
    Publication type:
    Article
    13

    Phase II trial of dacomitinib, a pan‒human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 11, p. 1522, doi. 10.1093/neuonc/nox105
    By:
    • Manuel Sepúlveda-Sánchez, Juan;
    • Ángeles Vaz, María;
    • Balañá, Carmen;
    • Gil-Gil, Miguel;
    • Reynés, Gaspar;
    • Gallego, Óscar;
    • Martínez-García, María;
    • Vicente, Elena;
    • Quindós, María;
    • Luque, Raquel;
    • Ramos, Ana;
    • Ruano, Yolanda;
    • Pérez-Segura, Pedro;
    • Benavides, Manuel;
    • Sánchez-Gómez, Pilar;
    • Hernández-Laín, Aurelio
    Publication type:
    Article
    14

    SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).

    Published in:
    Clinical & Translational Oncology, 2024, v. 26, n. 11, p. 2856, doi. 10.1007/s12094-024-03456-x
    By:
    • Vaz-Salgado, María Ángeles;
    • García, Belén Cigarral;
    • Pérez, Isaura Fernández;
    • Munárriz, Beatriz Jiménez;
    • Domarco, Paula Sampedro;
    • González, Ainhoa Hernández;
    • Villar, María Vieito;
    • Caro, Raquel Luque;
    • Delgado, María Luisa Villamayor;
    • Sánchez, Juan Manuel Sepúlveda
    Publication type:
    Article
    15

    SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).

    Published in:
    Clinical & Translational Oncology, 2022, v. 24, n. 4, p. 703, doi. 10.1007/s12094-022-02803-0
    By:
    • Martínez-García, María;
    • Servitja Tormo, Sonia;
    • Vilariño Quintela, Noelia;
    • Arance Fernández, Ana;
    • Berrocal Jaime, Alfonso;
    • Cantos Sánchez de Ibargüen, Blanca;
    • Del Barco Berrón, Sonia;
    • García Campelo, Rosario;
    • Gironés Sarrió, Regina;
    • Manuel Sepúlveda-Sánchez, Juan
    Publication type:
    Article
    16
    17

    A Pilot, Phase II, Randomized, Open‐Label Clinical Trial Comparing the Neurotoxicity of Three Dose Regimens of Nab‐Paclitaxel to That of Solvent‐Based Paclitaxel as the First‐Line Treatment for Patients with Human Epidermal Growth Factor Receptor Type 2‐Negative Metastatic Breast Cancer

    Published in:
    Oncologist, 2019, v. 24, n. 11, p. e1024, doi. 10.1634/theoncologist.2017-0664
    By:
    • Ciruelos, Eva;
    • Apellániz‐Ruiz, María;
    • Cantos, Blanca;
    • Martinez‐Jáñez, Noelia;
    • Bueno‐Muiño, Coralia;
    • Echarri, Maria‐Jose;
    • Enrech, Santos;
    • Guerra, Juan‐Antonio;
    • Manso, Luis;
    • Pascual, Tomas;
    • Dominguez, Cristina;
    • Gonzalo, Juan‐Francisco;
    • Sanz, Juan‐Luis;
    • Rodriguez‐Antona, Cristina;
    • Sepúlveda, Juan‐Manuel
    Publication type:
    Article
    18
    19

    Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

    Published in:
    Targeted Oncology, 2020, v. 15, n. 5, p. 613, doi. 10.1007/s11523-020-00754-6
    By:
    • Sepúlveda-Sánchez, Juan Manuel;
    • Gil-Gil, Miguel;
    • Alonso-García, Miriam;
    • Vaz Salgado, María Ángeles;
    • Vicente, Elena;
    • Mesía Barroso, Carlos;
    • Rodríguez Sánchez, Ángel;
    • Durán, Gema;
    • De Las Peñas, Ramón;
    • Muñoz-Langa, José;
    • Velasco, Guillermo;
    • Hernández-Laín, Aurelio;
    • Hilario, Amaya;
    • Navarro Martín, Miguel;
    • Benavides, Manuel;
    • Oleaga, Laura;
    • Cantero Montenegro, Diana;
    • Ruano, Yolanda;
    • Sánchez-Gómez, Pilar;
    • Martín-Soberón, María Cruz
    Publication type:
    Article